摄入低剂量阿姆洛迪平后的严重非心脏性肺:一个病例报告
Fares Abboud1, Mustafa Zain2, Ahmad Alsaadi2
1Faculty of Medicine, Damascus University, Damascus, Syria.
Annals of medicine and surgery (2012)
|November 3, 2025
概括
本案例研究详细介绍了一例罕见的严重非心脏性肺 (NCPE) 病例,该病例发生在服用低剂量常见高血压药物安洛迪平的患者身上. 症状在停用阿姆洛迪平后消失,并在重新暴露时复发.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 阿姆洛迪平是一种广泛处方的二皮里丁通道阻断剂,用于高血压.
- 周围水是常见的副作用,但非心脏性肺水 (NCPE) 是罕见的,通常与过量服用有关.
- 本报告侧重于一种严重的NCPE病例,该病例发生在低治疗用氨基胺剂量下.
研究的目的:
- 报告一种罕见的严重非心脏性肺 (NCPE) 病例,与低剂量安洛迪平相关.
- 突出阿姆洛迪平因甚至在治疗水平上也可能导致NCPE的潜力.
- 强调在不明原因的NCPE病例中考虑安洛迪平的重要性.
主要方法:
- 一个40岁的男性新诊断高血压,每天接受阿姆洛迪平5毫克的治疗.
- 诊断评估包括体检,成像和测量肺毛细管压力.
- 在意外再次暴露于阿姆洛迪平后观察症状的复发.
主要成果:
- 患者出现了严重的呼吸不良,缺氧 (SpO2 68%) 和短呼吸 (38次/分钟),与NCPE一致.
- 肺毛细血管压低 (8 mmHg),心声回声正常,排除了心脏病引起的原因.
- 停用安洛迪平导致了快速的临床改善,并且在意外再次摄入时症状复发.
结论:
- 这是第一次报告与低剂量安лоди平相关的严重NCPE病例.
- 再次暴露后的复发表明了潜在的关联,尽管因果关系尚未得到最终证实.
- 临床医生应将阿姆洛迪平视为NCPE的潜在原因,并立即停止使用,以改善患者的治疗结果.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:25Aortic Regurgitation III: Medical Management
385
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
385
01:29Cardiomyopathy VI: Nursing Management
309
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
309
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
01:30Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
01:22Acute Kidney Injury VI: Nursing Management
376
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
376